I'm just excited that the Trulieve news will create volume for the first time in forever. Lotta people bullish on the news despite the dilution so it'll be interesting to see the varying forces clash against one another. We have a broad market crater, which MSOs most often correlate to. We have dilution, which stonks typically dump on. But we also have a fairly bullish-leaning acquisition that is a necessary step to make TRUL a legit MSO as they add a ton of value. Based on the cultivation size, TRUL will be at 90k once the funded expansion is done. Cresco is at 95k, CURA 125k, TER 120k so they are right up there with the leaders in the state. As I said, part of the price they'll have to pay in being in a single state is that expansion to other states will be a lotttttttt more expensive than it was for other MSOs. But being so profitable in a single state allows them to have the balance sheet to do it. Plus, if they need to dilute any more to do it, they absolutely can and still be terrific value. Their market cap still ain't crazy.